RSS

David O'Connell

David O'Connell, PCI highlights the company’s expertise via an overview of its granulation service Read more

Opinion

David O’Connell, director of Scientific Affairs at PCI Pharma Services looks at the ways in which pharmaceutical manufacturers can overcome challenges in potent compound granulation. Read more

Opinion

David O’Connell, director of scientific affairs at PCI Pharma Services, discusses the principles of roller compaction – particularly in the development and manufacturing of solid oral dosage forms containing highly potent active pharmaceutical ingred Read more

Opinion

David O’Connell, director Pharmaceutical Development at PCI Pharma Services discusses the advantages of dry granulation as an alternative to traditional wet granulation for the development and manufacturing of solid oral dosage forms… Read more

Opinion